insider24.ch
Back to the feed

Shareholding disclosure

New Enterprise Associates 15 L.P

inAddex Therapeutics Ltd

Declared position

3%

Threshold

Fell below threshold

Timeline

Published

29.08.2024

Transaction

22.08.2024

Transfer date

23.08.2024

Voting rights breakdown

Voting rights acquired0%
Voting rights sold0%
Below threshold3%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

ZA01-000000000OX94

Beneficial owner

New Enterprise Associates 15 L.P

Declared address

New Enterprise Associates 15 L.P., Timonium, MD 21093, US

Fund management company of Growth Equity Opportunities Fund IV, LLC is New Enterprise Associates 15 L.P.

Open shareholder profileOpen company profile

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open